City of Hope licenses its unique gene editing technology to Homology Medicines Inc.
Clients City of Hope
Jones Day advised City of Hope in connection with an exclusive, worldwide license of its pioneering AAV-based gene editing technology to Homology Medicines Inc., a newly-formed genetic medicines company. A City of Hope lab developed the single platform technology that enables both gene editing and gene therapy with a built-in in vivo delivery system. The foundation technology is a novel non-nuclease based gene editing platform that is initially being developed to help find cures for rare genetic diseases.